Variant report
Variant | nsv8903 |
---|---|
Chromosome Location | chr12:9375688-9381273 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:9378550..9380275-chr12:9397056..9399605,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PZP-1 | chr12:9381129-9381294 | ENSG00000256359 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000256427 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146334127 | chr12:9375702-9375703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139578793 | chr12:9375714-9375715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547323305 | chr12:9375743-9375744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144211457 | chr12:9375766-9375767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191713557 | chr12:9375818-9375819 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146051748 | chr12:9375843-9375844 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148711153 | chr12:9375844-9375845 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142475373 | chr12:9375877-9375878 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185031175 | chr12:9375925-9375926 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs151323586 | chr12:9375984-9375985 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140574671 | chr12:9376045-9376046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74060664 | chr12:9376103-9376104 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs7298108 | chr12:9376168-9376169 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs145501749 | chr12:9376198-9376199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77229653 | chr12:9376242-9376243 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187573695 | chr12:9376258-9376259 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377626900 | chr12:9376269-9376270 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74060666 | chr12:9376311-9376312 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs4459362 | chr12:9376351-9376352 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs113897774 | chr12:9376388-9376389 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs145801967 | chr12:9376400-9376401 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11393143 | chr12:9376407-9376408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4883222 | chr12:9376415-9376416 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs4883223 | chr12:9376580-9376581 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs2889719 | chr12:9376595-9376596 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs77600844 | chr12:9376633-9376634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2217228 | chr12:9376649-9376650 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs147799916 | chr12:9376702-9376703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539496482 | chr12:9376738-9376739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371616286 | chr12:9376759-9376760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28728001 | chr12:9376760-9376761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2195210 | chr12:9376788-9376789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs575647919 | chr12:9376790-9376791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192812295 | chr12:9376800-9376801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184353786 | chr12:9376821-9376822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs137944295 | chr12:9376836-9376837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149031544 | chr12:9376839-9376840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555243245 | chr12:9376920-9376921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572299988 | chr12:9376921-9376922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2195211 | chr12:9377006-9377007 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs2195212 | chr12:9377049-9377050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs577736674 | chr12:9377054-9377055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189162031 | chr12:9377225-9377226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7978537 | chr12:9377322-9377323 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs371034572 | chr12:9377332-9377333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6487680 | chr12:9377351-9377352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs7978746 | chr12:9377437-9377438 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs549395941 | chr12:9377450-9377451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142881046 | chr12:9377453-9377454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150636583 | chr12:9377499-9377500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Epilepsy | 21858020 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Alzheimer''s disease | 17160897 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:9357400-9384800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
2 | chr12:9374400-9375800 | Weak transcription | HepG2 | liver |
3 | chr12:9374400-9392600 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
4 | chr12:9374600-9380200 | Weak transcription | Fetal Lung | lung |
5 | chr12:9374800-9375800 | Weak transcription | Liver | Liver |
6 | chr12:9375800-9376000 | Flanking Active TSS | Liver | Liver |
7 | chr12:9375800-9376600 | Enhancers | HepG2 | liver |
8 | chr12:9376000-9376200 | Enhancers | Liver | Liver |
9 | chr12:9376200-9376400 | Flanking Active TSS | Liver | Liver |
10 | chr12:9376200-9392600 | Weak transcription | Primary T cells from cord blood | blood |
11 | chr12:9379000-9379200 | Enhancers | Primary T cells fromperipheralblood | blood |
12 | chr12:9379200-9385800 | Weak transcription | Primary T cells fromperipheralblood | blood |
13 | chr12:9380200-9381200 | Enhancers | Fetal Lung | lung |
14 | chr12:9380200-9386000 | Weak transcription | Spleen | Spleen |
15 | chr12:9380400-9381400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr12:9380600-9381000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |